In conclusion, our results demonstrated that fucoidan analog 10, with a Type III structure containing repeating 2,3-O-sulfated α(1,4)-linked L-fucose, exhibited significant suppressive activity against the proliferation of malignant gastric cancer cells via galectin-4 inhibition. This evidence concerns the gene LGALS4 and gastric cancer.